Stay updated on Efficacy & Safety Biosimilar vs Enbrel Clinical Trial

Sign up to get notified when there's something new on the Efficacy & Safety Biosimilar vs Enbrel Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy & Safety Biosimilar vs Enbrel Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update in the efficacy or safety comparison between GP2015 and Enbrel in patients with moderate to severe chronic plaque-type psoriasis.
    Difference
    0.1%
    Check dated 2024-06-06T14:26:02.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' The new description provides examples of eligibility criteria, such as a person's general health condition or prior treatments, and includes specific inclusion and exclusion criteria for the study.
    Difference
    13%
    Check dated 2024-05-22T20:54:42.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:56:54.000Z thumbnail image

Stay in the know with updates to Efficacy & Safety Biosimilar vs Enbrel Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy & Safety Biosimilar vs Enbrel Clinical Trial page.